chartwatch, page-48

$1.25 short term target achieved.
However I will not entertain the thought of trading in and out of this baby. Hope Im wrong but I would expect a retrace/consolidation here at $1.25. Short term traders could feel some pain, unless of course large pharmaceutical sharks are circling and preparing to launch an opportunistic attack. They can have mine for $50 a pop.
The potential upside here is simply mind boggling.
A single shot cure for HIV and or HepC and a 25 billion dollar market cap will look cheap and so will a
$100.00 share price.
Shoot for the stars.